Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FCSC - Fibrocell Science Inc.

Previous close
2.99
0   0%

Share volume: 0
Last Updated: Thu 12 Dec 2019 06:00:00 AM CET
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
$2.99
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
18%
Profitability 33%
Dept financing 17%
Liquidity 27%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$2.99
P/E Ratio 
N/A
DAY RANGE
$2.99 - $2.99
EPS 
-$0.17
52 WEEK RANGE
$1.45 - $3.28
52 WEEK CHANGE
$50.00
MARKET CAP 
29.274 M
YIELD 
N/A
SHARES OUTSTANDING 
9.758 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$7,429,849
AVERAGE 10 VOLUME 
$71,259
AVERAGE 30 VOLUME 
$59,849
Company detail
CEO: John M. Maslowski
Region: US
Website: http://fibrocellscience.com
Employees: 19
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA.

Recent news